These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33021734)

  • 1. Ground Glass-Like Inclusions: Associated with Liver Toxicity.
    Deniz K
    Turk Patoloji Derg; 2021; 37(1):51-55. PubMed ID: 33021734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ground-glass hepatocellular inclusions are associated with polypharmacy.
    Lu HC; González IA; Byrnes K
    Ann Diagn Pathol; 2021 Jun; 52():151740. PubMed ID: 33836412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ground-glass, polyglucosan-like hepatocellular inclusions: A "new" diagnostic entity.
    Lefkowitch JH; Lobritto SJ; Brown RS; Emond JC; Schilsky ML; Rosenthal LA; George DM; Cairo MS
    Gastroenterology; 2006 Sep; 131(3):713-8. PubMed ID: 16952540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver glycogen bodies: ground-glass hepatocytes in transplanted patients.
    Bejarano PA; Garcia MT; Rodriguez MM; Ruiz P; Tzakis AG
    Virchows Arch; 2006 Nov; 449(5):539-45. PubMed ID: 17024424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ground-glass-like hepatocellular inclusions in the course of adult-onset Still's disease.
    Sari A; Tunakan M; Ozmen M; Turkkan E
    Mod Rheumatol; 2010 Feb; 20(1):90-2. PubMed ID: 19802652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lafora-like ground-glass inclusions in hepatocytes of pediatric patients: a report of two cases.
    O'Shea AM; Wilson GJ; Ling SC; Minassian BA; Turnbull J; Cutz E
    Pediatr Dev Pathol; 2007; 10(5):351-7. PubMed ID: 17929993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic disease associated with ground-glass inclusions in hepatocytes after cyanamide therapy.
    Bruguera M; Lamar C; Bernet M; Rodés J
    Arch Pathol Lab Med; 1986 Oct; 110(10):906-10. PubMed ID: 3021086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rethinking fibrinogen storage disease of the liver: ground glass and globular inclusions do not represent a congenital metabolic disorder but acquired collective retention of proteins.
    Zen Y; Nishigami T
    Hum Pathol; 2020 Jun; 100():1-9. PubMed ID: 32330484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult polyglucosan body disease: a rare presentation with chronic liver disease and ground-glass hepatocellular inclusions.
    Hajdu CH; Lefkowitch JH
    Semin Liver Dis; 2011 May; 31(2):223-9. PubMed ID: 21538287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ipilimumab-associated Hepatitis: Clinicopathologic Characterization in a Series of 11 Cases.
    Johncilla M; Misdraji J; Pratt DS; Agoston AT; Lauwers GY; Srivastava A; Doyle LA
    Am J Surg Pathol; 2015 Aug; 39(8):1075-84. PubMed ID: 26034866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyanamide-induced liver dysfunction after abstinence in alcoholics: a long-term follow-up study on four cases.
    Suzuki Y; Yokoyama A; Nakano M; Okuyama K; Takahashi H; Tamai H; Maruyama K; Ishii H
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):100S-105S. PubMed ID: 10803790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ground-glass hepatocytes with Lafora body like inclusions--histochemical, immunohistochemical and electronmicroscopic characterization.
    Ng IO; Sturgess RP; Williams R; Portmann B
    Histopathology; 1990 Aug; 17(2):109-15. PubMed ID: 2172143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.
    Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R
    Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen pseudoground glass change in hepatocytes.
    Wisell J; Boitnott J; Haas M; Anders RA; Hart J; Lewis JT; Abraham SC; Torbenson M
    Am J Surg Pathol; 2006 Sep; 30(9):1085-90. PubMed ID: 16931952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Puncture biopsy of the liver in phalloid hepatitis. 16 cases].
    Barge J; Sicot C; Orcel L; Mignot J
    Arch Anat Pathol (Paris); 1969 Sep; 17(3):153-8. PubMed ID: 5358486
    [No Abstract]   [Full Text] [Related]  

  • 16. Resistance of ground glass hepatocytes to oral antivirals in chronic hepatitis B patients and implication for the development of hepatocellular carcinoma.
    Tsai HW; Lin YJ; Wu HC; Chang TT; Wu IC; Cheng PN; Yen CJ; Chan SH; Huang W; Su IJ
    Oncotarget; 2016 May; 7(19):27724-34. PubMed ID: 27027237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type II ground-glass hepatocytes as a marker of hepatocellular carcinoma in chronic hepatitis B.
    Mathai AM; Alexander J; Kuo FY; Torbenson M; Swanson PE; Yeh MM
    Hum Pathol; 2013 Aug; 44(8):1665-71. PubMed ID: 23574780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ground-glass hepatocytes in fibrinogen storage disease in Japanese Black calves.
    Yamada M; Nakamura K; Nakajima Y; Yamamoto M; Komae H; Okuda K; Tsuji M; Arai M
    J Comp Pathol; 2002; 126(2-3):95-9. PubMed ID: 11944997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyanamide-associated alcoholic liver disease: a sequential histological evaluation.
    Yokoyama A; Sato S; Maruyama K; Nakano M; Takahashi H; Okuyama K; Takagi S; Takagi T; Yokoyama T; Hayashida M
    Alcohol Clin Exp Res; 1995 Oct; 19(5):1307-11. PubMed ID: 8561306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C.
    Rakoski MO; Brown MB; Fontana RJ; Bonkovsky HL; Brunt EM; Goodman ZD; Lok AS; Omary MB;
    Clin Gastroenterol Hepatol; 2011 Oct; 9(10):902-909.e1. PubMed ID: 21782771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.